Thirona, a Dutch company specialising in AI-powered medical lung image analysis, has announced the sale of its Thirona Retina BV division to Icare Finland Oy, a subsidiary of Revenio Group Corporation. This strategic move, finalised on 20 August 2024, allows Thirona to concentrate on its core focus of pulmonary diseases and interventional pulmonology, while positioning […]
German diagnostic company osteolabs GmbH has published groundbreaking real-world evidence data from nearly 3,000 patient samples, demonstrating the potential of their proprietary Calcium Isotope Marker (CIM) technology in early osteoporosis risk assessment. The study, published in the journal Bone, [1] marks a significant advancement in the field of metabolic bone disease diagnostics.
In a strategic move to expand its chemistry technology portfolio, Asynt Ltd has completed the acquisition of flow chemistry specialist Uniqsis. The deal, finalised on 31 August 2024, encompasses the transfer of all Uniqsis staff, intellectual property, and equipment stock.
In a significant move set to reshape AI-driven drug discovery, Recursion and Exscientia have announced an agreement to combine their operations. The merger, expected to close by early 2025, aims to create a global technology-enabled drug discovery leader with end-to-end capabilities.
In a significant development for the field of flow chemistry, engineering specialists Vapourtec have announced a collaboration with Accelerated Materials to expand the application of machine learning (ML) in chemical optimisation processes. This partnership aims to improve the efficiency and accuracy of predictive modelling in flow chemistry, a technique increasingly utilised in pharmaceutical research and […]
SGS, a global leader in testing, inspection, and certification, has announced the introduction of new specialised bioanalytical testing services for the North American pharmaceutical and biopharmaceutical markets. This expansion marks a significant development in the company’s capabilities to support drug development processes across various clinical trial phases.
In a significant development for the life sciences sector, Electron Microscopy Sciences (EMS) and Azer Scientific have merged to form Biolyst Scientific. The new company has an extensive portfolio of over 30,000 products spanning microscopy, histology, and other research domains.
Ventri Labs AB, a new subsidiary of Biotech Fluidics, has unveiled an innovative pump technology that could revolutionise the handling of sensitive biological materials in medical and research applications.
A groundbreaking collaboration between leading biotechnology companies and research organisations in the UK and Canada has secured £1.1 million in funding to develop a next-generation cell platform for viral vector production. The project, led by VVector Bio and including the National Research Council of Canada (NRC), Revvity, and Abselion, aims to address critical bottlenecks in […]
By Dr Ahmed Bentahar Dr Bentahar received his MD and PhD from État de Liège University, Belgium, and his master’s degree in health management and leadership from the European Institute of Health and Social Wellbeing in Madrid. As a member of the Sociedad Española de Hematología y Hemoterapia (SEHH) and Asociación Española de Biopatología Médica […]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
